<SEC-DOCUMENT>0001193125-17-185636-index.html : 20170526 <SEC-HEADER>0001193125-17-185636.hdr.sgml : 20170526 <ACCEPTANCE-DATETIME>20170526163129 ACCESSION NUMBER: 0001193125-17-185636 CONFORMED SUBMISSION TYPE: S-3 PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20170526 DATE AS OF CHANGE: 20170526 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SANGAMO THERAPEUTICS, INC CENTRAL INDEX KEY: 0001001233 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 680359556 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-218294 FILM NUMBER: 17874397 BUSINESS ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 BUSINESS PHONE: 5109706000 MAIL ADDRESS: STREET 1: 501 CANAL BLVD STREET 2: POINT RICHMOND TECH CNTR. CITY: RICHMOND STATE: CA ZIP: 94804 FORMER COMPANY: FORMER CONFORMED NAME: SANGAMO BIOSCIENCES INC DATE OF NAME CHANGE: 20000208 </SEC-HEADER> <DOCUMENT> <TYPE>S-3 <SEQUENCE>1 <FILENAME>d404725ds3.htm <DESCRIPTION>S-3 <TEXT> Document 1 - file: d404725ds3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.8 <SEQUENCE>2 <FILENAME>d404725dex48.htm <DESCRIPTION>EX-4.8 <TEXT> Document 2 - file: d404725dex48.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-4.10 <SEQUENCE>3 <FILENAME>d404725dex410.htm <DESCRIPTION>EX-4.10 <TEXT> Document 3 - file: d404725dex410.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>4 <FILENAME>d404725dex51.htm <DESCRIPTION>EX-5.1 <TEXT> Document 4 - file: d404725dex51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-12.1 <SEQUENCE>5 <FILENAME>d404725dex121.htm <DESCRIPTION>EX-12.1 <TEXT> Document 5 - file: d404725dex121.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.2 <SEQUENCE>6 <FILENAME>d404725dex232.htm <DESCRIPTION>EX-23.2 <TEXT> Document 6 - file: d404725dex232.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>g404725g85h57.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 7 - file: g404725g85h57.jpg
</DOCUMENT> </SEC-DOCUMENT>